Safety, Tolerability, Pharmacokinetics and Efficacy of Twice Daily Application of Topical BioLexa in Adult Healthy Subjects and Patients With Mild to Moderate Atopic Dermatitis
Clinical trial NCT04544943 · COMPLETED
Trial details
- NCT number
- NCT04544943
- Sponsor
- Hoth Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-17
- Primary completion
- 2022-09-21
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.